Dentobaume

Quick links to important sections

Dentobaume

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dentobaume

Quick Facts

Property Description
Active Ingredients Amylocaine, Levomenthol
Form Gingival Solution (Topical Liquid)
Pharmacological Class Local Anesthetic, Antalgic/Analgesic
Common Use Symptomatic relief of acute gingivodental discomfort
Origin Semisynthetic

What Type of Medicine is Dentobaume?

Dentobaume is a specialized topical preparation classified primarily as a local anesthetic and antalgic (pain-relieving) combination product used for buccodental application. The medicine is formulated as a concentrated gingival solution, a liquid form specifically designed for targeted, immediate administration to the oral mucosa and gums.

This formulation places it within the therapeutic category for symptomatic relief of localized discomfort. Amylocaine itself is historically recognized as one of the first synthetic local anesthetic agents functioning by stabilizing nerve membranes to block pain signals. The localized application of anesthetics is a standard practice for managing acute mucosal pain, offering rapid onset of relief.

What is Dentobaume's Composition and Purpose?

Dentobaume's efficacy is founded upon the complementary actions of two distinct active ingredients: Amylocaine (often used as the hydrochloride salt) and Levomenthol. Its general therapeutic purpose is to achieve rapid, symptomatic relief of acute discomfort in the mouth, such as that associated with temporary gingivodental irritation.

The composition utilizes Amylocaine, the synthetic component that furnishes the primary anesthetic effect, and Levomenthol (l-Menthol), which is the naturally-occurring monoterpenoid derivative contributing distinct anti-irritant and cooling properties. The efficacy of Levomenthol as a counter-irritant is clinically recognized for providing effective superficial pain relief. This fixed, dual-component approach is a defining feature of the preparation, ensuring both targeted numbing and sensory relief, thereby offering a comprehensive symptomatic action for temporary oral distress.

What side effects are possible with Dentobaume?

Possible side effects and safety information

The official safety profile for this topical gingival solution is structured around the officially documented risks of its active components, Amylocaine (a local anesthetic) and Levomenthol (a counter-irritant). Adverse reactions are categorized by their nature: local effects at the site of application and systemic effects due to absorption.

Official Adverse Reaction Categories

Classification Type Examples of Reactions Affected Systems
Common / Expected Local irritation, transient burning sensation, mild redness (erythema). Skin and Subcutaneous Tissue Disorders
Rare / Infrequent Localized allergic reactions (e.g., urticaria, edema). Skin and Subcutaneous Tissue Disorders
Serious Adverse Reactions Seizures, cardiac arrest (due to severe systemic toxicity), and Methemoglobinemia. Nervous System, Cardiovascular, Blood and Lymphatic System

Safety Considerations and Constraints

The serious adverse reactions are generally associated with systemic toxicity following rapid or excessive drug absorption. Signs of toxicity, such as drowsiness, lightheadedness, or confusion, are documented as potential early indicators of high blood levels.

Regulatory documents highlight specific safety considerations for susceptible patient populations. Caution is mandated for infants, children, and elderly patients, as well as those with compromised health, such as hepatic impairment or specific blood disorders (e.g., G6PD deficiency). The core action of the medicine presents inherent constraints, as the temporary numbness may impair swallowing or increase the danger of accidental biting trauma to the treated area. The concurrent use of other local anesthetics or oxidizing agents may further impact safety.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Dentobaume, typically resulting from over-application or accidental ingestion of the concentrated solution, primarily involves Local Anesthetic Systemic Toxicity (LAST) due to the Amylocaine component.

Domain Official Regulatory Statements
Documented Overdose Presentations Overexposure may begin with prodromal Central Nervous System (CNS) signs, including perioral numbness, metallic taste, dizziness, and agitation. Ingestion may also cause gastrointestinal distress (nausea, vomiting).
Serious / Life-Threatening Outcomes Toxicity can rapidly escalate to convulsions (seizures), respiratory depression, and severe cardiovascular manifestations such as hypotension, bradycardia, cardiac arrhythmias, and cardiac arrest.
Population-specific Overdose Notes Elderly or debilitated patients, those with cardiac, hepatic, or renal impairment, and pediatric patients are noted in official labeling to be at an increased risk of severe systemic toxicity.
Emergency-response statements Immediate medical attention is required upon the onset of any neurologic or cardiovascular symptoms. Life-threatening signs mandate immediately seeking emergency services (NIH [1.2], [2.2]).

The official profile specifies that no specific antidote is known for the local anesthetic effect; management is strictly symptomatic and supportive. Regulatory documents detail management procedures including airway stabilization, seizure control with specific medications (e.g., benzodiazepines), and the use of Intravenous Lipid Emulsion Therapy (ILE) for confirmed severe systemic toxicity (NIH [3.1]). Continuous monitoring of vital signs and ECG is required for stability (NIH [3.1]).

Therapeutic Uses of Dentobaume

What Dentobaume Treats: Main Uses and Benefits

The primary therapeutic role of Dentobaume is to provide targeted, temporary symptomatic support for acute discomfort in the mouth. It is applied across domains where additional symptomatic support is needed to ease the overall burden of challenging oral manifestations. This product's category is used for temporary relief of pain and irritation in contexts consistent with guidance for topical anesthetics.

Symptomatic Relief and Core Indications

The solution is applied in situations involving certain distressing symptoms, generally including acute gingivodental pain, oral mucosal irritation, and associated soreness. It is relevant for easing temporary functional strain, such as discomfort arising from dental appliances or minor oral lesions. The medication may assist with managing symptoms that interfere with daily comfort. This supportive approach is relevant, as symptoms that interfere with daily functioning may create noticeable physiological strain.

Clinical Scenarios and Patient Benefit

Dentobaume is commonly used when short-term symptomatic assistance is needed during phases when oral symptoms become more noticeable. Applied in scenarios where additional management of discomfort is required, the medication provides supportive relief that helps patients cope more steadily with difficult episodes. It contributes to easing the overall symptom load by addressing localized physical discomfort, which assists with maintaining functional stability when symptoms are more noticeable.

Quick Fact Relief for Acute Gingivodental Discomfort
Primary Focus Symptoms related to localized physical discomfort
Use Context Short-term symptomatic assistance
Benefit Supports maintenance of functional stability

Regulatory References

  1. Health Canada guidance on topical anesthetics

Eligibility and Restrictions for Use

Who Can and Cannot Use Dentobaume?

Eligibility for Dentobaume (Amylocaine Hydrochloride/Levomenthol) is strictly defined by regulatory documents, primarily restricting use based on age, allergies, and specific health conditions.

Contraindications and Exclusions

Category Restriction Status
Children under 10 years of age Contraindicated (Absolutely Prohibited)
History of allergy to local anesthetics Contraindicated
Known hypersensitivity to Amylocaine, Levomenthol, or excipients Contraindicated

Restricted and Conditional Use

Use is reserved for adults and children 10 years of age and older. Additional restrictions apply to specific populations:

  • Pregnancy and Lactation: Use is not recommended due to an absence of sufficient safety data and, for breastfeeding, the potential for neurological effects in the infant linked to the Levomenthol component.
  • History of Epilepsy: Individuals with an ancient or recent history of epilepsy must seek medical advice before use, as the product contains terpene derivatives that can affect the epileptogenic threshold.
  • Older Adults: Caution is advised, as the labeling indicates a potential for agitation or confusion if recommended doses are exceeded.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for this topical solution is largely defined by its specific component properties and mandatory administration constraints, rather than extensive systemic drug-drug interactions.

Interaction Scope and Restrictions

Element Official Regulatory Status
Documented Systemic Drug-Drug Interactions No specific systemic drug-drug, metabolic, or transporter-based interactions are documented in the official prescribing information.
Food and Beverage Interaction Interaction with food or beverages is formally documented as Not Applicable.
Mandatory Restriction The solution must not be mixed with other medicinal products due to an official lack of documented compatibility studies.

Pharmacodynamic Precaution

Regulatory labeling includes a specific pharmacodynamic precaution related to one of the active components. This product contains Levomenthol, which is classified as a terpene derivative. Due to the component’s capacity to lower the seizure threshold, special precaution is officially required for patients with a documented history of epilepsy. This constitutes the primary population-specific interaction consideration documented in the official prescribing information.

Summary of Interaction Profile

The overall interaction structure is characterized by the absence of documented systemic interactions, consistent with its topical use. Regulatory documents focus on a clear prohibition of co-mixing the solution with other medicines and highlight the precautionary requirement for the epileptic population due to the known effect of the terpene derivative.

Mechanism of Action

Inhibition of Peripheral Action Potential Conduction

The primary mechanism involves Amylocaine acting as a use-dependent blocker on neuronal voltage-gated sodium channels ( Na v) in peripheral sensory nerves. By inhibiting the rapid influx of Na^+ ions, this mechanism stabilizes the neuronal membrane and interrupts the electrical impulse conduction in sensory neurons. The physiological consequence of this targeted blockade is a localized, temporary suppression of somatic sensory input due to the cessation of nerve signal propagation.


Sensory Modulation via Peripheral TRPM8 Activation

The complementary action is exerted by Levomenthol, which functions as an agonist on the TRPM8 (Transient Receptor Potential) sensory channels located on peripheral nerve endings. This interaction artificially lowers the activation threshold of these cold-sensitive receptors, triggering an immediate Ca^2+ influx that is perceived as a cooling sensation. This physiological response modulates local sensory input, acting as a counter-stimulus that creates an overriding sensory input during the initiation phase of the impulse blockade mechanism.

Dosage and Administration Information

Administration and Official Usage Protocol

Dentobaume is strictly for local administration via the topical route within the oral cavity. As a gingival solution, the medicine is applied directly to the site of discomfort and is not intended for systemic ingestion. The formulation is a combination product containing 0.80 grams of Amylocaine hydrochloride and 0.80 grams of Levomenthol per 100 grams of solution.


Dosing and Application Method

The official administration protocol defines the dose as a single application. The medication requires specific preparation before use: an absorbent material, such as a cotton pad or swab, must be impregnated with the solution. This saturated material is then placed directly onto the painful gum or tooth.

The usage pattern is inherently short-term, limited to providing symptomatic support during acute episodes of discomfort. This intermittent frequency, dependent on the persistence of symptoms, establishes the medication's role as temporary analgesic assistance.

Usage Parameter Regulatory Guideline
Dosing Unit One application of an impregnated pad or cotton.
Frequency Pattern As-needed (PRN), with renewal permissible in the course of the day according to the intensity of pain.
Minimum Age Reserved for adults and children over 10 years of age.
Procedural Constraint Must not be mixed with other medicines.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dentobaume


Evidence for Symptomatic Relief of Acute Oral Discomfort

Research exploring the active components in Dentobaume—local anesthetics and counter-irritants—for localized discomfort in the mouth often includes Randomized Controlled Trials (RCTs). These short-term studies are designed to compare the measured effect of an active topical preparation against a control, or against another form of standard care. Research has explored the active agents in studies examining patient-reported experiences when acute, localized discomfort arises, such as following certain dental procedures or due to temporary irritation.

Studies reported measurements of changes in pain intensity following application. The studies explored outcomes related to physical discomfort, tracking how symptoms evolved in the observed populations immediately following use. Findings describe the measured time to sensory effect, consistent with the expected pharmacological class. The research is focused on short-term or episodic symptom patterns, and results apply only to the specific circumstances and populations studied.


Observation Periods and Limitations

Research exploring the usefulness of topical oral anesthetics is primarily built on short follow-up durations. The maximum observation periods in key trials typically range from a few minutes (to assess the onset of action) up to 72 hours (3 days) after a specific event. These studies were designed to evaluate short-term, acute symptomatic changes, relevant in trials assessing episodic symptom patterns.

Because of this design, the long-term effects are not fully established. There is limited information for long-term outcomes, and the duration of symptomatic observation related to this pharmacological class is brief. The evidence quality varies across studies due to differences in formulation types and concentrations, and data for certain groups remain insufficient, particularly for individuals with complex medical histories or chronic oral conditions.

Key Studies & References Health Canada Guidance on Labelling Standards for Topical Anaesthetic Analgesic Antipruritic

Frequently Asked Questions (FAQ)

Common questions about Dentobaume (FAQ)


Q: Is Dentobaume an analgesic or an antiseptic, or both?

According to official regulatory documents, Dentobaume is classified as a local anesthetic and an antalgic (a product used to relieve pain). The preparation is designed to offer symptomatic relief for discomfort. The official product documentation does not classify or indicate that it is intended for use as an antiseptic.


Q: Is it safe to use Dentobaume if I'm taking blood thinners?

The official prescribing information for this topical solution does not list documented systemic drug-drug interactions with blood thinners (anticoagulants). Official guidelines recommend informing a healthcare professional of all current medications before initiating any treatment.


Q: Should Dentobaume be stored in the refrigerator?

No, official storage guidelines specify that Dentobaume must be stored at controlled room temperature, typically below 25 C to 30 C. The regulatory information also explicitly states that the solution should not be frozen to maintain its stability and effectiveness.


Q: What should I do if my pain gets worse after using Dentobaume?

Dentobaume is intended only for temporary and symptomatic pain relief. If symptoms worsen or persist, discontinuation of use and consultation with a qualified healthcare professional is advised, as the product is intended only for temporary relief.


Q: Can Dentobaume be used to help with teething pain in infants? (seeking general product info)

No, regulatory documents strictly state that Dentobaume is contraindicated (absolutely prohibited) for use in children under 10 years of age. The official documentation states this age restriction due to considerations related to the active ingredients.


Q: Are there any long-term side effects if Dentobaume is used frequently?

Official research on the active ingredients in this formulation is primarily based on short observation periods, often up to 72 hours (3 days). Studies focused on acute, short-term symptom relief. Due to this design, the long-term effects of frequent or prolonged use are not fully established by the available data.


Q: Does Dentobaume interact with herbal supplements like St. John's Wort?

The official prescribing information does not document any specific systemic interactions with herbal supplements. However, regulatory constraints mandate that the solution must not be mixed with any other medicinal products. When considering use, official information emphasizes informing a healthcare provider about all current medications and supplements.


Q: What does 'for temporary relief' mean in the context of Dentobaume?

According to official regulatory definitions, 'for temporary relief' means the usage is intended to be short-term and intermittent. The medicine is meant to provide symptomatic support only during acute episodes of discomfort and is not intended for chronic, continuous treatment.


Q: Does Dentobaume have an expiration date?

Yes, regulatory guidelines for safe handling and disposal include specific instructions for discarding unused or expired product. This requirement confirms that the medication has a documented expiration date for quality and effectiveness, which should be referenced before use.


Q: What is the consistency of Dentobaume (e.g., liquid, gel, paste)?

Dentobaume is formulated as a concentrated gingival solution. This classification indicates that the medicine is a liquid topical preparation designed specifically for targeted application to the oral mucosa and gums.


Q: How quickly should I feel relief after applying Dentobaume?

Relief is expected to begin shortly after application, as the time to sensory effect is consistent with the rapid onset of its pharmacological class (local anesthetics).


Q: How long does the numbing effect of Dentobaume typically last?

Dentobaume is designed to provide a localized, temporary suppression of pain sensation. The effect is intended for short-term symptomatic use during acute episodes, and the duration of relief is episodic rather than prolonged.


Q: Is it normal to feel a strong tingling or burning sensation right after applying Dentobaume?

Official safety information documents that common adverse reactions include both local irritation and a transient burning sensation at the site of application. This effect is generally transient, as it is listed as a common but temporary sensation in safety documents.


Q: What happens if I accidentally swallow a small amount of Dentobaume?

The product is not intended for systemic ingestion. Regulatory documents describe signs of systemic toxicity, such as drowsiness, lightheadedness, or confusion, that may occur following excessive absorption.


Q: How often can Dentobaume be applied in a 24-hour period?

Official dosing guidelines state that the application can be renewed in the course of the day as needed. The frequency is determined by the intensity of the pain and the persistence of the symptoms.


Q: Is there a maximum number of days I should use Dentobaume continuously?

Usage is defined as inherently short-term symptomatic relief. Although no absolute maximum duration is mandated, the supportive research on the product typically focuses on short periods, with maximum observation periods of up to 72 hours (3 days).


Q: Are there any restrictions on eating or drinking after applying Dentobaume?

Due to the risk of accidental biting trauma and impaired swallowing from temporary numbness, official warnings advise caution regarding eating or drinking until the effect has subsided.


Q: What signs of an allergic reaction to Dentobaume should I watch out for?

Official documents list rare signs of localized allergic reactions, including urticaria (hives/itchy rash) or edema (swelling) at the application site.


Q: Can I apply Dentobaume with a cotton swab or my finger?

The official administration protocol requires the use of an absorbent material to apply the medicine. Specifically, a cotton pad or swab must be impregnated with the solution and then placed directly onto the painful gum or tooth.

How should Dentobaume be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory guidelines for this topical liquid preparation strictly define the environmental conditions required to maintain its stability and effectiveness.

Storage Condition Category Regulatory Requirement
Temperature Requirements Store at controlled room temperature, typically below 25 C to 30 C.
Environmental Protection Protect from light and moisture. Do not freeze the solution.
Container Requirements Keep the product in its original container and ensure the cap is tightly closed.
Child Safety Storage The medicine must be stored out of the sight and reach of children.
Disposal Instructions Unused or expired Dentobaume must be disposed of according to local pharmaceutical regulations. It should not be flushed down a toilet or sink, nor discarded in the household trash, to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dentobaume found in:

A-Z Index: